 |
MS Egypt Chapter urges public awarenessThe MS Chapter of the Egyptian Society of Neurology, Psychiatry, and Neurosurgery (ESNPN), urged better public understanding of the disease that affects 2.5 million people worldwide, on the occasion of World Multiple Sclerosis (MS) Day. More… |
 |
Sanofi says MS treatment reduced relapse rateSanofi said on Friday a trial of its multiple-sclerosis treatment teriflunomide found that a daily dose of the drug reduced the rate of relapse by 36 per cent compared with a placebo. Teriflunomide, marketed as Aubagio, is one of the two m More… |
 |
Kuwait societies aim to raise MS awarenessTwo major medical and cultural societies in Kuwait have joined hands with local experts to raise awareness of the neurological disorder Multiple Sclerosis (MS) through a series of educational talks. “Most of the MS information on the Inter More… |
 |
Dubai to host region’s first MS patient forumThe Middle East’s first-ever multiple sclerosis (MS) patient forum will take place this weekend in Dubai, officials said at the launch of an MS awareness bus tour today (March 27) at Rashid Hospital. The MS awareness bus tour’s first stop More… |
 |
UAE sets up task force to combat MSThe Emirates Neurology Society (Emins) has set up the first-ever national taskforce to tackle multiple sclerosis (MS), a nervous system disease with no known cause that affects the brain and spinal cord, in the UAE. Acting under the umbrel More… |
 |
Bahrain licences first MS oral drugBahrain has licensed the world’s first oral medication for Multiple Sclerosis (MS), a nervous system disease that affects the brain and spinal cord leading to symptoms such as visual disturbances and muscle weakness. The Bahrain Ministry o More… |
 |
Brain infections reported with MS drugMore than 100 cases of a potentially fatal brain infection have been reported among patients who took Biogen Idec's multiple sclerosis drug Tysabri, US health officials said. The Food and Drug Administration also said it was updating presc More… |
 |
Sun exposure, vitamin D linked to MS riskPeople who have spent more time in the sun and those with higher vitamin D levels may be less likely to develop multiple sclerosis (MS), according to an Australian study. Previous studies have shown that people living close to the equator More… |
 |
Multiple Sclerosis to come under focusThe effects of Multiple Sclerosis (MS) the debilitating neurological disorder that attacks the central nervous system will be in focus during a dedicated one-day conference at the upcoming Arab Health Congress 2011. Arab Health, one of the More… |
 |
Novartis gets US backing for MS pillSwiss drugmaker Novartis AG's multiple sclerosis pill Gilenya won US backing, putting it ahead of German rival Merck KGaA in the race to be first with an oral treatment in the United States. The US Food and Drug Administration's back More… |
